imatinib has been researched along with Hypereosinophilic Syndrome in 2 studies
Hypereosinophilic Syndrome: A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Q | 1 |
| Liu, F | 1 |
| Qi, S | 1 |
| Qi, Z | 1 |
| Yan, XE | 1 |
| Wang, B | 1 |
| Wang, A | 1 |
| Wang, W | 2 |
| Chen, C | 1 |
| Liu, X | 1 |
| Jiang, Z | 1 |
| Hu, Z | 1 |
| Wang, L | 1 |
| Ren, T | 1 |
| Zhang, S | 1 |
| Yun, CH | 1 |
| Liu, Q | 1 |
| Liu, J | 1 |
| Řezníčková, E | 1 |
| Gucký, T | 1 |
| Kováčová, V | 1 |
| Ajani, H | 1 |
| Jorda, R | 1 |
| Kryštof, V | 1 |
2 other studies available for imatinib and Hypereosinophilic Syndrome
| Article | Year |
|---|---|
Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFRα kinase inhibitor for PDGFRα driving chronic eosinophilic leukemia.
Topics: Acrylamides; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Proliferation; Dose-Respons | 2018 |
Activity of 2,6,9-trisubstituted purines as potent PDGFRα kinase inhibitors with antileukaemic activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; | 2019 |